• GLAXOSMITHKLINE PLC Financial Overview

  • Income Statement: GSK

      2007 2006 Change ( 2006 - 2007  )
    Net Sales/Revenues 45.61 B 43.15 B 2.46 B 5.39%
    Gross Profit 35.16 B 33.84 B 1.31 B 3.73%
    Net Income Before Extra Items/Preferred Div 10.47 B 10.01 B 455.76 M 4.35%
    Operating Income 14.97 B 13.94 B 1.03 B 6.90%
  • Cash Flow: GSK

      2007 2006 Change ( 2006 - 2007  )
    Net Cash Flow - Financing -2.91 B -8.12 B 5.22 B -179.41%
    Net Cash Flow - Investing 6.56 B 3.41 B 3.15 B 48.04%
    Net Cash Flow/Operating Activities 12.13 B 7.91 B 4.22 B 34.80%
  • Balance Sheet: GSK

      2007 2006 Change ( 2006 - 2007  )
    Total Assets 57.16 B 45.85 B 11.31 B 19.78%
    Total Liabilities 37.49 B 26.97 B 10.52 B 28.07%
    Shareholders Equity 19.05 B 18.37 B 685.67 M 3.60%
  • Key Ratios / Statistics: GSK

    • Valuation

      Price/Earnings (TTM) 13.29
      Price/Sales (TTM) 3.05
      Price/Book (MRQ) 7.70
      Price/Cash Flow (TTM) 9.49
    • Profitability

      Gross Margin 77.08
      Operating Margin 32.82
      Profit Margin 22.95
    • Dividends

      Dividend Paid (TTM) 2.20
      Payout Ratio % (TTM) 58.80
    • Financial Strength

      Quick Ratio (MRQ) 1.00
      Current Ratio (MRQ) 1.78
      Long Term Debt-to-Equity (MRQ) 168.94
    • Management Effectiveness

      Return on Equity (TTM) 57.00
      Return on Assets (TTM) 19.47
      Return on Investments (TTM) 31.18